Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients

Idiopathic pulmonary fibrosis (IPF) lacks effective treatment. Pirfenidone has been used to treat IPF patients. N-acetylcysteine (NAC) exerts antioxidant and antifibrotic effects on IPF cases. This study is a double-blind, modified placebo-controlled, randomized phase II trial of pirfenidone in Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hui, Dai, Hua Ping, Kang, Jian, Chen, Bao Yuan, Sun, Tie Ying, Xu, Zuo Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620844/
https://www.ncbi.nlm.nih.gov/pubmed/26496265
http://dx.doi.org/10.1097/MD.0000000000001600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620844/
https://www.ncbi.nlm.nih.gov/pubmed/26496265
http://dx.doi.org/10.1097/MD.0000000000001600

Ejemplares similares